Nonoptimal infant neuromotor development was linked to genetic risk for schizophrenia, but not bipolar disorder.
Specific inflammatory biomarkers may have an impact on the risk of developing schizophrenia.
Poor adherence to antipsychotic treatment in schizophrenia may be attributable to socially negative representations of schizophrenia.
Patients with schizophrenia, schizoaffective disorder, and psychotic bipolar disorder were examined for anticholinergic burden.
NMDA receptor signaling is increased in patients with depression and reduced in those with schizophrenia.
Having schizophrenia and a length of stay of 90 days or more were the strongest predictors of polypharmacy.
The odd relationship may have more to do with the mental disorder than the drugs.
Researchers uncovered a link between elevated levels of C4A protein, excessive synaptic pruning, and the development of schizophrenia.
A mouse model of schizophrenia showed a significant decrease in inhibitory CA2 neurons.
The unique biotypes may allow for more targeted treatments to be developed.
Patients taking clozapine were less likely to need additional antipsychotic medications.
A 1 cm deficit in PCS length contributed to a 20% increased risk for hallucinations.
The most common side effect reported was akathisia.
The personalized approach to treatment could help prevent trial-and-error periods.
The FDA's approval was based on data from controlled trials in adults with manic or mixed episodes of bipolar I disorder and schizophrenia.
Second-generation antipsychotics appear to have a neuroprotective effect on the brain.
Automated speech analysis more accurately classified at-risk young people than clinical ratings.
A three-month course of daily omega-3 supplements prevented the progression to a psychotic disorder in the majority of participants.
The game is designed to improve episodic memory.
Identifying the abnormalities may help in the development of news treatments.
The FDA has granted Fast Track designation to encenicline for the treatment of cognitive impairment in schizophrenia.
Aerobic activity seems to be beneficial, but the results of the study need to be duplicated.
Neurology Advisor Articles
- Multiple System Atrophy: A Common Form of Atypical Parkinsonism
- Migraine Treatment in the ED: Overcoming Our Penchant for Opioids
- Erenumab as a Therapy for Hard to Treat Episodic Migraine
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy
- Reduced Survival for Patients With Idiopathic Parkinsonism
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Biomarkers of Alzheimer Disease Observed in Down Syndrome
- Short Segment Sensory Nerve Stimulation Offers Potential Diagnostic Value for Ulnar Neuropathy
- Incidence of Guillain-Barré Syndrome Linked With Recent Bone, Digestive Organ Surgery
- Online Tool Helps Patients With Advance Care Planning
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds